Investigation of novel derivatives of dexrazoxane reveals topoisomerase II beta interaction as a pre-requisite for effective protection against anthracycline cardiotoxicity
Event:
Heart Failure 2018
Topic:
Experimental Heart Failure
Session:
Chronic Heart Failure – Pathophysiology and Mechanisms